Arvis Liepiņš

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

   · 2016 · cited 5,303x

2. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

   · 2016 · cited 974x

3. Haplotype-resolved diverse human genomes and integrated analysis of structural variation

   · 2021 · cited 641x

4. Characterizing the Major Structural Variant Alleles of the Human Genome

   · 2019 · cited 405x

5. Segmental duplications and their variation in a complete human genome

   · 2022 · cited 317x

via Crossref · CC0

Wikidata facts

Mass

77

Image

Arvis Liepiņš.JPG

Height

187

via Wikidata · CC0